HG381

HG381 · HitGen Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HG381, covering 2025-03-13 to 2025-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HG381 Administered to Patients With Advanced Solid Tumors [Phase 1]